Snejdrlova M, Kalvach Z, Topinkova E, Vrablik M, Prochazkova R, Kvasilova M, Lanska V, Zlatohlavek L, Prusikova M, Ceska R.
Journal Article 2011; 32(Suppl 2): 51-54 PubMed PMID: 22101883 Keywords: Aged:physiology, Aged, 80 and over, Apolipoprotein E2:genetics, Apolipoprotein E3:genetics, Apolipoprotein E4:genetics, Apolipoproteins E:genetics, Female, Genetic Fitness:genetics, Heterozygote, Humans, Life Expectancy, Logistic Models, Longevity:genetic. CitationOBJECTIVES: Life expectancy is determined by a combination of genetic predisposition (~25%) and environmental influences (~75%). Neverthel.....
Snejdrlova M, Kalvach Z, Topinkova E, Vrablik M, Prochazkova R, Kvasilova M, Lanska V, Zlatohlavek L, Prusikova M, Ceska R. APOE polymorphism as a potential determinant of functional fitness in the elderly regardless of nutritional status. Neuro Endocrinol Lett. 2011 Jan; 32(Suppl 2): 51-54
Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R.
Controlled Clinical Trial 2008; 29(1): 146-150 PubMed PMID: 18283261 Keywords: Aged, Biomarkers:blood, Cardiovascular Diseases:blood, Cholesterol, LDL:blood, Diabetes Mellitus, Type 2:blood, Female, Fenofibrate:adverse effects, Humans, Lipoproteins:blood, Male, Middle Aged, Peroxisome Proliferator-Activated Receptors:agonists, Phosp. CitationBACKGROUND: Particle size distribution in both HDL and LDL is reflected in the fractional esterification rate of cholesterol by lecithin c.....
Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R. Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus. Neuro Endocrinol Lett. 2008 Feb; 29(1): 146-150
OBJECTIVES: The aim of the study was to evaluate skin microvascular reactivity (MVR) measured by laser Doppler flowmetry in women early af.....
Prázný M, Fait T, Vrablik M. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy. Neuro Endocrinol Lett. 2007 Aug; 28(4): 496-501
Fait T, Vrablik M, Cibula D, Masata J, Hill M, Trnkova B.
Journal Article 2006; 27(5): 665-668 PubMed PMID: 17159824 Keywords: Administration, Cutaneous, Administration, Oral, Adult, Antithrombin III:analysis, Cross-Over Studies, Estradiol:administration & dosage, Estrogen Replacement Therapy:methods, Female, Fibrinogen:analysis, Humans, Lipoproteins:blood, Middle Aged, Postmenop. CitationOBJECTIVES: The purpose of the present study was to determine changes of biochemical risk factors of thromboembolism especially of TFPI du.....
Fait T, Vrablik M, Cibula D, Masata J, Hill M, Trnkova B. Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study. Neuro Endocrinol Lett. 2006 Oct; 27(5): 665-668